A composition and an associated method of treating cancer cells by impeding cancer cell growth with the composition are disclosed. The composition includes at least a first and a second HMG-CoA reductase inhibitor, wherein the total amount of the first and second HMG-CoA reductase inhibitors is effective in synergistically impeding cancer cell growth and wherein the cancer cell growth synergistic impedance from the total amount of the first and second HMG-CoA reductase inhibitors is greater than a theoretical additive effect from the combined first and second HMG-CoA reductase inhibitors. The present composition does not simultaneously contain both a tocotrienol and an ionone when the composition contains only a first and a second HMG-CoA reductase inhibitor. The method includes treating cancer cells with the claimed composition to impede cancer cell growth.
本发明公开了一种通过使用该组合物抑制癌细胞生长来治疗癌细胞的组合物和相关方法。该组合物至少包括第一种和第二种
HMG-CoA还原酶
抑制剂,其中第一种和第二种
HMG-CoA还原酶
抑制剂的总量能有效地协同阻碍癌细胞生长,并且第一种和第二种
HMG-CoA还原酶
抑制剂总量产生的癌细胞生长协同阻碍作用大于第一种和第二种
HMG-CoA还原酶
抑制剂组合产生的理论相加作用。当组合物仅含有第一和第二种
HMG-CoA 还原酶
抑制剂时,本组合物不会同时含有
生育三烯酚和离子酮。该方法包括用所述组合物治疗癌细胞,以阻碍癌细胞生长。